Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma

Acta Haematologica

Volumn 116, Issue 3, 2006, Pages 181-185

  Baráth, Sándor ^a   Aleksza, Magdolna ^a   Keresztes, Katalin ^a   Tóth, Judit ^a   Sipka, Sándor ^a   Szegedi, Gyula ^b   Illés, Árpád ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

CD4+ IL 10+; CD4+CD25high; CD8+ IL 10+; Hodgkin's lymphoma

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; CANCER REGRESSION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIGENS, CD8; CD4 LYMPHOCYTE COUNT; FEMALE; HODGKIN DISEASE; HUMANS; INTERLEUKIN-10; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 33749576080     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094678     Document Type: Article

References (17)

1. Poppema S: Immunology of Hodgkin's disease; in Diehl V (ed): Baillières Clin Haematol. London, Baillière Tindall, 1996, vol 9, pp 447-457.
2. Reed DM: On pathological changes in Hodgkin's disease, with especial reference to its relation to tuberculosis. John Hopkins Hosp Rep 1902;10:133-196.
3. Green I, Course PF: A study of skin homografting in patients with lymphomas. Blood 1959;14:235-245.
4. Miller DG, Lizardo JG, Synderman RK: Homologous and heterologous skin transplantation in patients with lymphomatous disease. J Natl Cancer Inst 1961;26:569-579.
5. Baglin TP, Joysey VC, Horsford J, Johnson RT, Broadbent V, Marcus RE: Transfusion-associated graft-versus-host disease in patients with Hodgkin's disease and T-cell lymphoma. Transfus Med 1992;2:195-199.
6. Levy R, Kaplan HS: Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med 1974;290:181-186.
7. Romagnani S, Del Prete GF, Maggi E, Bosi A, Bernardi F, Ponticelli P, Di Lollo S, Ricci M: Displacement of T lymphocytes with the 'helper/inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease. Scand J Haematol 1983;31:305-314.
8. Poppema S, Bahn AK, Reinherz EL Posner MR, Schlossman SF: In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved in Hodgkin's disease. Blood 1982;59:226-232.
9. Poppema S, Visser L, Jiang XY: In vitro system for evaluation of the immunomodulatory capacity of CD45(R) reagents. Transplant Proc 1996;28:3263-3264.
10. Rubinstein E, Sokal JE, Reisman RE, Arbesman CE: Relationship of total IgE and cell-mediated immunity in patients with Hodgkin's disease. Int Arch Allergy Appl Immunol 1977;55:439-443.
11. Hellinger SM, Herzig GP: Impair cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest 1978;61:1620-1627.
12. Marshall AN, Christie EL, Munro RL, Culligan JD, Johnston WP, Barker NR, Vickers AM: Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004;103:1755-1762.
13. Akbari O, Stock P, DeKruyff RH, Umetsu DT: Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003;15:627-633.
14. + T suppressor lymphocytes. Clin Exp Med 2004;4:86-92.
15. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: WHO classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Va., November 1997. J Clin Oncol 1999;17:3835-3849.
16. + regulatory T cells in patients with gastrointestinal malignances: possible involvement of regulatory T cells in disease progression. Cancer 2003;98:1089-1099.
17. high regulatory T cells in patients with chronic lymphocytic leukaemia after therapy with fludarabine. Blood May 25; DOI 10.1182/blood-2005-02-0642.